Damage-Associated Molecular Patterns in Inflammatory Diseases

키워드

참고문헌 (92)

1. Albiger B, "Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors", J Intern Med, 261, pp.511~528 (2007)[DOI]
2. 이명섭, "Pattern-Recognition Receptor Signaling Initiated From Extracellular, Membrane, and Cytoplasmic Space", Molecules and Cells, 23(1), pp.1~10 (2007), 한국분자세포생물학회
3. Feldman N, "DAMPs as mediators of sterile inflammation in aging-related pathologies", Ageing Res Rev, 24, pp.29~39 (2015)[DOI]
4. Medzhitov R, "Inflammation 2010: new adventures of an old flame", Cell, 140, pp.771~776 (2010)[DOI]
5. Scrivo R, "Inflammation as "common soil" of the multifactorial diseases", Autoimmun Rev, 10, pp.369~374 (2011)[DOI]
6. Chen GY, "Sterile inflammation: sensing and reacting to damage", Nat Rev Immunol, 10, pp.826~837 (2010)[DOI]
7. Venereau E, "DAMPs from cell death to new life", Front Immunol, 6, pp.422~ (2015)
8. Land WG, "The role of damage-associated molecular patterns (DAMPs) in human diseases: part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine", Sultan Qaboos Univ Med J, 15, pp.157~170 (2015)
9. Matzinger P, "Tolerance, danger, and the extended family", Annu Rev Immunol, 12, pp.991~1045 (1994)[DOI]
10. Schaefer L, "Complexity of danger: the diverse nature of damage-associated molecular patterns", J Biol Chem, 289, pp.35237~35245 (2014)[DOI]
11. Zhang X, "Macrophage activation by endogenous danger signals", J Pathol, 214, pp.161~178 (2008)[DOI]
12. Smiley ST, "Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4", J Immunol, 167, pp.2887~2894 (2001)[DOI]
13. Sokolove J, "Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and <TEX>$Fc{\gamma}$<", TEX> receptor, 2011, pp.63, 53~62
14. Sohn DH, "Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4", Arthritis Res Ther, 14, pp.R7~ (2012)[DOI]
15. Ye RD, "Emerging functions of serum amyloid A in inflammation", J Leukoc Biol, 98, pp.923~929 (2015)[DOI]
16. Klune JR, "HMGB1: endogenous danger signaling", Mol Med, 14, pp.476~484 (2008)
17. Bertheloot D, "HMGB1, IL-<TEX>$1{\alpha}$<", TEX>, IL-33 and S100 proteins: dual-function alarmins, 2017, pp.14, 43~64
18. Foell D, "S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules", J Leukoc Biol, 81, pp.28~37 (2007)[DOI]
19. Zhou YJ, "The heat shock protein-CD91 pathway mediates tumor immunosurveillance", OncoImmunology, 3, pp.e28222~ (2014)[DOI]
20. Mariathasan S, "Cryopyrin activates the inflammasome in response to toxins and ATP", Nature, 440, pp.228~232 (2006)[DOI]
21. Gasse P, "Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis", Am J Respir Crit Care Med, 179, pp.903~913 (2009)[DOI]
22. 진효선, "Mitochondrial Control of Innate Immunity and Inflammation", Immune Network, 17(2), pp.77~88 (2017), 대한면역학회[DOI]
23. Santoni G, "Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons", J Neuroinflammation, 12, pp.21~ (2015)[DOI]
24. Jimenez-Dalmaroni MJ, "The critical role of toll-like receptors - from microbial recognition to autoimmunity: a comprehensive review", Autoimmun Rev, 15, pp.1~8 (2016)[DOI]
25. Kufer TA, "Innate immune sensing of microbes by Nod proteins", Ann N Y Acad Sci, 1072, pp.19~27 (2006)[DOI]
26. Schroder K, "The inflammasomes", Cell, 140, pp.821~832 (2010)[DOI]
27. Loo YM, "Immune signaling by RIG-I-like receptors", Immunity, 34, pp.680~692 (2011)[DOI]
28. Geijtenbeek TB, "Signalling through C-type lectin receptors: shaping immune responses", Nat Rev Immunol, 9, pp.465~479 (2009)[DOI]
29. PrabhuDas MR, "A consensus definitive classification of scavenger receptors and their roles in health and disease", J Immunol, 198, pp.3775~3789 (2017)[DOI]
30. McInnes IB, "The pathogenesis of rheumatoid arthritis", N Engl J Med, 365, pp.2205~2219 (2011)[DOI]
31. van Boekel MA, "Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value", Arthritis Res, 4, pp.87~93 (2002)
32. Baillet A, "Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases", Rheumatology (Oxford), 49, pp.671~682 (2010)[DOI]
33. Andres Cerezo L, "Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis", Arthritis Res Ther, 19, pp.79~ (2017)[DOI]
34. Goldstein RS, "Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis", Mol Med, 13, pp.210~215 (2007)
35. Taniguchi N, "High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine", Arthritis Rheum, 48, pp.971~981 (2003)[DOI]
36. Li YB, "Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression", Mol Cell Biochem, 420, pp.161~170 (2016)[DOI]
37. Schierbeck H, "Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models", Mol Med, 17, pp.1039~1044 (2011)
38. Kokkola R, "Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity", Arthritis Rheum, 48, pp.2052~2058 (2003)[DOI]
39. Andersson U, "High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes", J Exp Med, 192, pp.565~570 (2000)[DOI]
40. Spierings J, "Heat shock proteins and their immunomodulatory role in inflammatory arthritis", Rheumatology (Oxford), 56, pp.198~208 (2017)[DOI]
41. Martin CA, "Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp", DC-mediated cross-priming, 2003, pp.171, 5736~5742
42. Huang QQ, "Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling", J Immunol, 182, pp.4965~4973 (2009)[DOI]
43. Hashiramoto A, "Heat shock protein 90 maintains the tumour-like character of rheumatoid synovial cells by stabilizing integrin-linked kinase, extracellular signal-regulated kinase and protein kinase B", Rheumatology (Oxford), 50, pp.852~861 (2011)[DOI]
44. Sohn DH, "Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis", Arthritis Rheumatol, 67, pp.2877~2887 (2015)[DOI]
45. Tsokos GC, "Systemic lupus erythematosus", N Engl J Med, 365, pp.2110~2121 (2011)[DOI]
46. Abdulahad DA, "High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus", Arthritis Res Ther, 13, pp.R71~ (2011)[DOI]
47. Jog NR, "Urinary high-mobility group box-1 associates specifically with lupus nephritis class V", Lupus, 25, pp.1551~1557 (2016)[DOI]
48. Schaper F, "Treatment with anti-HMGB1 monoclonal antibody does not affect lupus nephritis in MRL", lpr mice, 2016, pp.22, 12~21
49. Caielli S, "Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus", J Exp Med, 213, pp.697~713 (2016)[DOI]
50. Lood C, "Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease", Nat Med, 22, pp.146~153 (2016)[DOI]
51. Sokolove J, "Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations", Ther Adv Musculoskelet Dis, 5, pp.77~94 (2013)[DOI]
52. Robinson WH, "Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis", Nat Rev Rheumatol, 12, pp.580~592 (2016)[DOI]
53. Kapoor M, "Role of proinflammatory cytokines in the pathophysiology of osteoarthritis", Nat Rev Rheumatol, 7, pp.33~42 (2011)[DOI]
54. Terada C, "Gene expression and localization of high-mobility group box chromosomal protein-1 (HMGB-1)in human osteoarthritic cartilage", Acta Med Okayama, 65, pp.369~377 (2011)
55. Sun XH, "Expression and Significance of high-mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-product (RAGE) in knee osteoarthritis", Med Sci Monit, 22, pp.2105~2112 (2016)[DOI]
56. Cremers NA, "S100A8", A9 increases the mobilization of pro-inflammatory Ly6Chigh monocytes to the synovium during experimental osteoarthritis, 2017, pp.19, 217~
57. Wang LC, "S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis", Biomarkers, 18, pp.216~220 (2013)[DOI]
58. Nakashima M, "Role of S100A12 in the pathogenesis of osteoarthritis", Biochem Biophys Res Commun, 422, pp.508~514 (2012)[DOI]
59. Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", N Engl J Med, 352, pp.1685~1695 (2005)[DOI]
60. Hansson GK, "The immune system in atherosclerosis", Nat Immunol, 12, pp.204~212 (2011)
61. Ruparelia N, "Inflammatory processes in cardiovascular disease: a route to targeted therapies", Nat Rev Cardiol, 14, pp.133~144 (2017)[DOI]
62. Inoue K, "HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques", Cardiovasc Pathol, 16, pp.136~143 (2007)[DOI]
63. Fiuza C, "Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells", Blood, 101, pp.2652~2660 (2003)[DOI]
64. McCormick MM, "S100A8 and S100A9 in human arterial wall. Implications for atherogenesis", J Biol Chem, 280, pp.41521~41529 (2005)[DOI]
65. Schiopu A, "S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease", Mediators Inflamm, 2013, pp.828354~ (2013)
66. Harja E, "Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-", - mice, 2008, pp.118, 183~194
67. Oesterle A, "S100A12 and the S100", calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets, 2015, pp.35, 2496~2507
68. Ligthart S, "EN-RAGE: a novel inflammatory marker for incident coronary heart disease", Arterioscler Thromb Vasc Biol, 34, pp.2695~2699 (2014)[DOI]
69. Berberian PA, "Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries", Am J Pathol, 136, pp.71~80 (1990)
70. Xiao Q, "Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study", Stroke, 36, pp.2571~2576 (2005)[DOI]
71. Zhao Y, "Heat shock protein 60 stimulates the migration of vascular smooth muscle cells via Toll-like receptor 4 and ERK MAPK activation", Sci Rep, 5, pp.15352~ (2015)[DOI]
72. Maneerat Y, "Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients", Lipids Health Dis, 15, pp.117~ (2016)[DOI]
73. Wilkinson K, "Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease", Int J Alzheimers Dis, 2012, pp.489456~ (2012)
74. Venegas C, "Danger-associated molecular patterns in Alzheimer's disease", J Leukoc Biol, 101, pp.87~98 (2017)[DOI]
75. Festoff BW, "HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease", J Neuroinflammation, 13, pp.194~ (2016)[DOI]
76. Chaves ML, "Serum levels of S100B and NSE proteins in Alzheimer's disease patients", J Neuroinflammation, 7, pp.6~ (2010)[DOI]
77. Cirillo C, "S100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer's disease", BioMed Res Int, 2015, pp.508342~ (2015)
78. Herrero MT, "Inflammation in Parkinson's disease: role of glucocorticoids", Front Neuroanat, 9, pp.32~ (2015)
79. Yang Y, "High expression of the HMGB1-TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging", Brain Behav, 8, pp.e00948~ (2018)[DOI]
80. Sasaki T, "Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease", Exp Neurol, 275, pp.220~231 (2016)[DOI]
81. Sathe K, "S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and <TEX>$TNF-{\alpha}$<", TEX> pathway, 2012, pp.135, 3336~3347
82. Schaf DV, "S100B and NSE serum levels in patients with Parkinson's disease", Parkinsonism Relat Disord, 11, pp.39~43 (2005)[DOI]
83. Hernandez C, "Damage-associated molecular patterns in cancer: a double-edged sword", Oncogene, 35, pp.5931~5941 (2016)[DOI]
84. Grivennikov SI, "Immunity, inflammation, and cancer", Cell, 140, pp.883~899 (2010)[DOI]
85. Haybaeck J, "A lymphotoxin-driven pathway to hepatocellular carcinoma", Cancer Cell, 16, pp.295~308 (2009)[DOI]
86. Obeid M, "Calreticulin exposure dictates the immunogenicity of cancer cell death", Nat Med, 13, pp.54~61 (2007)[DOI]
87. Ghiringhelli F, "Activation of the NLRP3 inflammasome in dendritic cells induces IL-<TEX>$1{\beta}$<", TEX>-dependent adaptive immunity against tumors, 2009, pp.15, 1170~1178
88. Apetoh L, "Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy", Nat Med, 13, pp.1050~1059 (2007)[DOI]
89. Schelbergen RF, "Alarmins S100A8", S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis, 2016, pp.75, 218~225
90. Fucikova J, "Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer", Front Immunol, 6, pp.402~ (2015)
91. Hendriks LE, "Heat shock protein antagonists in early stage clinical trials for NSCLC", Expert Opin Investig Drugs, 26, pp.541~550 (2017)[DOI]
92. Koffeman EC, "Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial", Arthritis Rheum, 60, pp.3207~3216 (2009)[DOI]

관련 논문AI추천